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Summary We have investigated the regression phenomenon which occurs when EBV-infected peripheral
blood mononuclear cells from seropositive individuals are cultured for one month at high cell concentration
and have confirmed that regression is mediated by E+ lymphocytes. When helper/inducer (Leu 3a+) and
suppressor/cytotoxic (Leu 2a+) cells are separated by fluorescence-activated cell sorting from fresh peripheral
blood and co-cultured with EBV-infected autologous E- mononuclear cells, regression only regularly occurs
in cultures receiving suppressor/cytotoxic lymphocytes. Titration experiments show that suppressor/cytotoxic
lymphocytes are more active in the regression assay that unfractionated E+ cells. When Ia+ E+ and Ia- E+
cells are separated one week after initiation of co-cultures of E+ cells and EBV-infected E- cells, both Ia+ E+
and Ia- E+ cells are active in the regression assay although regression occurs earlier in cultures receiving Ta+
E+ cells. Experiments in which NK cells are isolated using the monoclonal antibodies H25 and H366 show
that NK cells do not influence the regression phenomenon in normal individuals.
Epstein-Barr virus (EBV) is a B lymphotrophic
human herpes virus which is the causative agent of
Infectious Mononucleosis (IM) (Henle et al., 1968)
and is aetiologically associated with Burkitt's
lymphoma (Epstein & Achong, 1979) and
nasopharyngeal carcinoma (Epstein, 1978). In most
individuals infection occurs subclinically during
childhood (Evans et al., 1968) and leads to the
production of antibodies to virus-determined
antigens which thereafter persist for life (Hewetson
et al., 1973). Following either IM or sub-clinical
infection EB virus persists in the body, and can be
found in saliva (Golden et al., 1973) and in
lymphoid tissue (Nilsson et al., 1971). This
persistent infection with EBV is probably, at least in
part, controlled by EBV-specific memory T cells
which have been demonstrated in the peripheral
blood of seropositive individuals (Moss et al., 1978).
These T cells are activated in cultures of EB virus-
infected peripheral blood mononuclear cells to
produce cytotoxic cells which then cause regression
of proliferating foci of the EB virus-infected B cells
within the culture (Rickinson et al., 1979) in an
HLA-restricted manner (Rickinson et al., 1980).
In the present study we have used the
fluorescence activated cell sorter (FACS) to separate
peripheral blood cells stained with monoclonal
antibodies into subsets with specific activities. These
subsets have then been assayed for their capacity to
cause regression of autologous EBV-infected B cell
targets.
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Materials and methods
Medium
RPMI 1640 medium containing 2mM glutamine,
100 IU penicillin and 100 IU streptomycin was used
throughout. 5mM HEPES buffer and 2% calf
serum were added for all cell preparation
procedures, and 20% v/v foetal calf serum (FCS)
was added for all culture procedures.
Donors
Normal healthy adults who were seropositive for
antibodies to EB virus were selected as leucocyte
donors.
Cellpreparation
Whole blood was diluted with an equal volume of
medium and centrifuged on a Ficoll-hypaque
gradient. The peripheral blood mononuclear cells
(PBMC) were harvested from the interface band
and washed twice in medium.
E rosettes were formed using AET-treated sheep
red cells by the method of Kaplan & Clark (1974)
and the E rosette-positive population (E+) was
separated from the E rosette-negative population
(E-) on a percoll gradient (Callard & Smith, 1981).
The E- cells were harvested from the interface band
and the E+ cells were recovered from the pellet by
lysis of the red cells with 0.83% ammonium
chloride. Both cell populations were washed twice
in medium before use.
(C) The Macmillan Press Ltd., 1983682 D.H. CRAWFORD et al.
EBV infection
Pellets of cells were infected with EBV by
resuspending them at a concentration of 10iml-'
in the supernatant medium of B95-8 cell line (Miller
et al., 1972), which had been filtered through a
0.45y filter. The suspension was incubated at 37°C
and shaken regularly. After 1 h the cells were
washed, resuspended in medium at the desired
concentration and cultured in microtest plate wells.
Antibody staining
The following antibodies were used:
(i) Leu 3a. This monoclonal antibody which is
specific for human helper/inducer T cells
(Becton Dickinson, Sunny Vale, California
94086, U.S.A.) was used at a final dilution of
1:200.
(ii) Leu 2a. This mouse monoclonal antibody
which is specific for suppressor/cytotoxic T
cells (Becton Dickinson) was used at a final
dilution of 1:100.
(iii) H25/H366. These two similar monoclonal
antibodies were raised by immunisation with
the HSB T-ALL-derived cell line. Biochemical
data suggest that they bind 2 different
polypeptide chains of the same molecular
complex. The antigens defined by the two
antibodies are found on human large granular
lymphocytes, some monocytes, a proportion of
thymocytes and T cells activated by mitogens
or grown in interleukin 2. The NK activity of
fresh PBMC is found exclusively within the
H25+ and the H366+ fractions. (B. Yan, et al.,
1983,). The culture supernatant media
containing these antibodies were mixed
together before use because clearer separation
of positive snd negative fractions was then
obtained.
(iv) RFB-HLA-DR. This monoclonal antibody (a
gift from Dr M. Bodger, Royal Free Hospital,
London) is directed against human HLA-DR
determinants (Bodger et al., 1983) staining B
lymphocytes, monocytes and activated T
lymphocytes in the peripheral blood.
(v) Sheep anti-mouse immunoglobulin (Sh anti
MIg) conjugated to fluorescein isothiocyanate
(FITC) was used at a final dilution to 1:30.
The cells to be stained were resuspended at a
concentration of 107/ml-1 in the unconjugated
antibody preparations which had been filtered
through a 0.22p filter. They were incubated at 4°C
for 30min washed twice in medium and then
resuspended in the diluted, filtered Sh anti MIg
FITC conjugated antibody at a concentration of
107 cells ml-1 and incubated for a further 30min at
4°C. After two washes the cells were resuspended in
medium at 5 x 106/ml-1 ready for analysis on the
FACS.
FACS analysis
The analysis and separation of FITC-labelled cells
were performed on a FACS-TI or a FACS IV
(Becton Dickinson FACS Systems, Mountain View,
California, U.S.A.). Relative light scatter and
fluorescence intensities were displayed as a 2-
dimensional dot plot. The standard conditions for
analysis and sorting were laser power-300 MW,
488nm, photomultiplier tube voltage 850V with
light scatter and fluorescence gain of 16. The
windows for separating the positively and
negatively stained cells were set using identical
criteria to Callard et al., 1982.
Cell culture
Unless otherwise stated cells were cultured in 0.2ml
aliquots in microtitre wells at a concentration of
2 x 106/ml-'. The cultures were incubated at 37°C
in a humidified atmosphere containing 5% CO2 and
fed weekly by replacement of half the medium
without disturbing the cell layer. They were
examined weekly under an inverted microscope for
the development of proliferating foci and for the
onset of regression. The incidence of regression or
transformation in each set of cultures was scored by
eye after one month.
Results
Monoclonal antibodies Leu 2a, Leu 3a and
H25/H366 have each been used to stain PBMC in 2
experiments. The percentage of PBMC which
stained with each antibody are shown in Table I.
Leu 2a stained 32% and 26% of PBM whereas Leu
3a stained 65% and 62%. H25/H366 stained 20% of
PBM in both experiments.
The E+ cells were separated into positively and
negatively staining populations using the FACS.
Unseparated PBM, and where possible an
unseparated, stained E+ cell population were
retained. Each population, as well as unseparated,
stained E+ cells, was washed, resuspended at
3 x 10 ml-1 and added in 0.1 ml aliquots to the
0.1 ml cultures of EBV-infected E- cells. Thus, each
well contained 4 x 105 cells with an E+:E- ratio of
3:1. To some wells containing the E- cells 0.1 ml of
medium alone was added.
In all the experiments control cultures containing
EBV-infected whole PBMC (at 4 x i05 well) and in
some experiments cultures containing EBV-infected
E- cells with stained, unseparated E+ cellsEB VIRUS-SPECIFIC MEMORY T CELLS 683
Table I Incidence of regression in cultures containing EBV-infected E- cells with
FACS-separated E+ subpopulations
(a) Antibody staining and FACS separations carried out on day 0
Incidence ofregression in cultures
Antigen' Antigen-
Antibody % PBM fraction fraction Total
Exp. No. used + PBM +E- +E- E+ +E- E- alone
1 Leu 2a 32 5/5 6/6 0/10 N.D. 0/10
2 Leu 2a 26 5/5 5/5 1/9 5/5 0/10
3 Leu 3a 65 5/5 0/10 4/4 10/10 0/10
4 Leu 3a 62 4/4 2/10 3/3 5/5 0/5
5 H25/366 20 5/5 0/4 4/4 N.D. 0/1
6 H25/366 20 5/5 0/6 5/5 N.D. 0/1
(b) Antibody staining and FACS separations carried out after 7 days of culture of
EBV-infected PBMC
Incidence ofregression in cultures
Antigen+ Antigen-
Antibody % PBM fraction fraction Total
Exp. No. used + PBM +E- +E- E++E- E- alone
7 RFB-HLA-DR 18 5/5 2/2 9/9 N.D. 0/4
8 RFB-HLA-DR 12 5/5 3/3 20/20 N.D. 0/5
(recombined in a 1:3 ratio, 10:3 x 105 cells/well)
were set up and all showed the expected regression
after a one-month culture period (Table I). In all
experiments the EBV-infected E- cell populations,
when cultured alone (105 cells/well) showed no
evidence of regression (Table I).
When E+ cells were separated into Leu 2a+ and
Leu 2a- populations and these cells were added to
EBV-infected E- cells in a 3:1 ratio (3 x 105:105
cells/well) all those cultures receiving the Leu 2a+
cells in both experiments showed regression (6/6
and 5/5 cultures) after a one-month culture period,
whereas out of all those receiving the Leu 2a- cells
in both experiments only one culture well showed
regression (0/10 and 1/9 cultures). EBV-transformed
cell lines were obtained from these cultures,
however the proliferating foci of cells appeared later
and grew slower than those in cultures containing
E- cells alone.
When experiments of exactly the same design
were carried out using E+ cells stained with Leu 3a
those cultures of EBV-infected B cells which
received the Leu 3a+ cells showed little evidence of
regression after a one-month culture period (0 out
of 10 and 2 out of 10) although the transformed foci
appeared later than those in the E- alone culture
wells. Conversely, when Leu 3a- cells were added
to cultures of EBV-infected E- cells all cultures
showed regression (4/4 and 3/3) (Table I).
In experiments using H25 and H366 antibodies
whole PBMC were stained with antibody and
separated into positive and negative fractions on the
FACS. Following this procedure the H25/H366
negative population was further separated into E+
and E- fractions. The H2S/H366 positive fraction
and the H25/H366 negative E+ fraction were then
recombined with EBV-infected E- cells for culture.
When H25/H366 positive cells were cultured with
EBV-infected E- cells no evidence of regression was
apparent in 2 identical experiments after a one-
month culture period. However, the proliferating
foci of cells appeared later in these cultures than in
those receiving EBV-infected E- cells alone.
Regression occurred in all culture wells containing
the H25/H366 negative E+ fractions (Table I).
In the one experiment in which cell numbers
allowed titration of the E+ Leu 2a+ and E+ Leu
2a- cells on a fixed number of EBV-infected E-
cells regression occurred in all the cultures
containing E+ cells seeded at 3 x 105 and 1.5 x 105
per well and in 4/5 cultures containing 7.5 x 104 or
3.75 x 104 E+ cells. No regression was seen at lower
E+ cell concentrations. Similarly complete
regression occurred in cultures containing Leu 2a+
cells down to a concentration of 3.75 x 104 per well,
and in 4/5 cultures containing 1.8 x 104 and 9 x 103
Leu 2a+ cells. No regression was apparent in any of
the cultures receiving Leu 2a- cells (Table II).684 D.H. CRAWFORD et al.
Table II Titration of suppressor/cytotoxic E+ cells added
to autologous EBV-infected E- cells
Incidence ofregression in cultures
containing:
No. ofE+ subfraction
added to 105 E- cells Leu 2a+ Leu 2a- E+
3 x 105 5/5 0/5 5/5
1.5 x 105 5/5 0/5 5/5
7.5 x 104 5/5 0/5 4/5
3.75 x 10 5/5 0/5 4/5
1.8 x 10i 4/5 0/5 0/5
9 x 103 4/5 0/5 0/5
In experiments using the RFB-HLA-DR antibody
PBMC were infected with EBV and cultured at 1-
2x 106ml-1 in 2ml costar wells. In each
experiment medium containing 1ygml-1 of
cyclosporin A (CSA) was added to 1 culture well.
After 0 and 7 days in culture the cells were E
rosetted, and the E+ fractions were stained with
RFB-HLA-DR. The E+ cells from cultures
containing medium with and without CSA were
analysed on the FACS.
The freshly isolated cells (Day 0) contained 2, <1
and 1% of E+ cells expressing Ta antigens whereas
in the respective 7 day non-CSA-containing cultures
24, 18 and 38% of E+ cells were Ia'. In 7 day
CSA-containing cultures 6, 8 and 10% of cells
expressed Ta (Table III). Those cells which had
been cultured without CSA were separated into
positively and negatively staining fractions. Both
fractions were cultured in 0.1 ml volumes at a
concentration of 3 x 106 ml -Iwith 0.1 ml of freshly
prepared EBV-infected, autologous E- cells at
1066ml-'. Cultures containing both the Ia' and the
Ta- E+ cells showed regression (Table I) although
the regression phenomenon was apparent earlier in
those cultures receiving the Ta+ E+ cells.
Table III Expression of RFB-HLA-DR on T
cells after a one week culture period with
autologous EBV-infected B cells with or
without CSA
% ofE+ cells which are Ia+
in EBV-infected cultures
Exp.
No. Day +CSA No CSA
1 0 2 2
7 6 24
2 0 <1 <1
7 8 18
3 0 1 1
7 10 38
Discussion
The phenomenon of regression in EBV-infected
cultures of PBMC from seropositive individuals has
been shown to be due to the presence of T cells in
the cultures which become cytotoxic for autologous
EBV-infected B cells (Rickinson et al., 1979).
However, other factors may also influence the final
outcome of regression or transformation of B cells
after a one-month culture period; in particular
interferon production by the cultured cells (Thorley-
Lawson, 1981) or NK cell activity may be
important. For this reason we decided to further
investigate the cell types involved in the generation
of regression.
In our experiments regression regularly occurred
in cultures of EBV-infected PBMC seeded at high
initial cell concentrations but was completely absent
when EBV-infected E- cells were cultured alone
(Table I). These results confirm the findings of other
workers (Rickinson et al., 1979), and indicate that
E+ cells are necessary in a culture for regression to
occur. When the FACS was used to separate Leu
2a+ (suppressor/cytotoxic)+ from Leu 2a- cells
regression only regularly occurred in cultures
receiving the Leu 2a+ cells. Conversely when Leu
3a (helper/inducer) antibody was used in identical
experiments only the cultures receiving Leu 3a-
cells regularly showed regression (Table I). When
the regression activity in Leu 2a+ and total E+ cell
fractions was titrated on fixed numbers of EBV-
infected E- cells, lower numbers of Leu 2a+ cells
could be used to cause complete regression
revealing an enrichment of effector cells in this cell
fraction (Table II).
These clear-cut results indicate that the cytotoxic
activity resides within the Leu 2a+, Leu 3a- T cell
fraction, and suggest that, in this system,
collaborative T-T cell interactions between
helper/inducer and suppressor/cytotoxic T cell
subsets as defined by Leu 2a and 3a play a minor
role in the generation of the cytotoxic cells. We
have similarly found little evidence for interaction
between these two subsets in the generation of help
or suppression for in vitro antibody responses to
influenza virus (Callard et al., 1982). However, it is
still possible that there may be further heterogeneity
within both subsets, and evidence for this has been
reported in response to pokeweed mitogen (Thomas
et al., 1981). Our findings may reflect the fact that
these cytotoxic T cells are constantly activated in
vivo by the low numbers of EBV-carrying B
lymphocytes known to be present in the circulation
of all seropositive individuals (Nilsson et al., 1971)
and that T-T interactions are important only in the
generation of primary responses. Since FCS has
been shown to selectively induce the generation of
cytotoxic T cells with a preferential lysis forEB VIRUS-SPECIFIC MEMORY T CELLS 685
autologous cell lines (Misko et al., 1982) we carried
out one further separation experiment using the
Leu 2a antibody in which all the cell cultures were
set up in medium containing 20% AB serum from a
seronegative donor in place of FCS. In this
experiment all the regression activity again occurred
in the cultures receiving Leu 2a+ cells, and thus an
active role for FCS in the generation of cytotoxic T
cells in our experiments was excluded.
Other workers have shown that the number of
cells with suppressor/cytotoxic phenotype (OKT8+)
is increased in cultures of PBMC after challenge
with the autologous EBV genome-containing B cell
lines, and that the cytotoxic response was abrogated
after removal of the OKT8+ population by
complement-mediated lysis (Tsoukas et al., 1981). In
the experiments presented here the use of the FACS
allowed the preservation of both positively- and
negatively-staining fractions which could then be
tested in parallel in the regression assay.
In our experiments using Leu 2a and Leu 3a
monoclonal antibodies it was noted that although
actively proliferating B cell lines were present after
a one-month period in those cultures receiving the
helper/inducer (Leu 2a-, Leu 3a+) cells, the
proliferating foci of EBV-transformed B cells
appeared later and initially grew at a slower rate
than those in cultures containing EBV-infected E-
cells alone. We further investigated this observation
by using the FACS to enrich NK cells (H25/H266+)
from PBMC. When these cells were cultured with
EBV-infected E- cells no regression was seen after
a one-month culture period; all the cytotoxic
activity was found to reside in the H25/H366- E+
cell fraction (Table I). Once again some delay in the
outgrowth of the proliferating foci of B cells was
noted in the cultures containing the enriched NK
cells when they were compared with the EBV-
infected E- cells early in the culture period. This
may have been due to NK cells acting against
EBV-infected targets early in the culture period, or
alternatively this early delay in outgrowth of EBV-
infected B cells may be due to the production of
interferon within the culture. This phenomenon has
been described previously (Thorley-Lawson, 1981)
and was not investigated further in our experiments
since it did not alter the final outcome of the
cultures from normal individuals when scored for
regression after one month. However, in certain
pathological situations enhancement or abrogation
of these subsidiary mechanisms may affect the
regression assay (Pereira et al., 1982).
HLA-DR antigens (Ia) are known to be expressed
on all human B lymphocytes, and have also been
described on a subset of T lymphocytes which
appear to be activated (Evans et al., 1978). In this
work we have studied the generation of Ia+ T cells
in cultures one week after EBV-infection of PBMC
when cytotoxic T cells are known to be present
(Moss et al., 1981). We have compared this with the
generation ofTa+ cells in identical cultures containing
CSA-a drug which is known to prevent the
generation of cytotoxic T cells and the regression
phenomenon (Bird et al., 1981). The levels of Ia+ T
cells in fresh PBMC is low (0-2%), and this
percentage rises after EBV-infection and 7 days in
culture (18-38%). The addition of CSA to the
culture medium can be seen to inhibit the
expression of Ta on cultured T cells (Table III) a
finding which has been reported using CSA in
autologous lymphocyte systems (Palacios & Moller,
1981). This finding suggests that the phenotype of
the actively cytotoxic cells is Ia' E+. FACS
separation of these Ta+ E+ cells from the Ia- E+
population shows that both fractions contain cells
which are capable of causing regression when
cultured with EBV-infected E- cells (Table I). Too
few Ta+ E+ cells were collected to perform a
titration experiment with these fractions, however
enrichment of the cytotoxic cells in the la' E+
fraction was suggested by a more rapid onset of
regression in cultures receiving these cells. Although
these cell culture experiments show that both the
Ta+ and Ta- E+ cells are capable of generating the
cytotoxic T cells which cause regression, the
possibility still remains that during the culture
period the Ta- cells become Ta+ before becoming
actively cytotoxic. This could be resolved using the
chromium release assay to assess the cytotoxicity of
the Ia' and Ia- E+ fractions immediately after
separation.
In conclusion, we have shown that in cultures of
PBMC from normal individuals the regression of
proliferating foci of EBV-infected B cells observed
after one month is caused by Leu 2a+ T cells which
are mostly Ta'.
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